FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024

Apr 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-15

Reporting Person: Haigh Adrian (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-15	Common Shares	S	22222	$2.31	Acquired	22222	Direct
2024-04-16	Common Shares	S	22222	$2.31	Acquired	44444	Direct
2024-04-15	Common Shares	S	22222	$10.2958	Disposed	22222	Direct
2024-04-16	Common Shares	S	22222	$10.2776	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-15	Common Shares	$2.31	M	22222	Disposed	2024-04-25	Options (22222)	Direct
2024-04-16	Common Shares	$2.31	M	22222	Disposed	2024-04-25	Options (22222)	Direct

Footnotes

F1: Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.

F2: Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.

F3: Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.

F4: Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.

F5: Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.

F6: Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.